BioCentury
ARTICLE | Company News

CardioGenesis Corp., Chiron deal

April 21, 1997 7:00 AM UTC

The companies will develop methods to enhance transmyocardial revascularization (TMR) to treat myocardial ischemia. CHIR will provide certain cardiovascular compounds, and CGCP will provide its epicar...